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Nakedmole rat (MR)Heterocephalus glaber is a rodentmodel
of delayed aging because of its unusually long life span (>28
years). It is also not known to develop cancer. In the current
work, tissue imaging by x-ray fluorescence microscopy and
direct analyses of trace elements revealed low levels of selenium
in the MR liver and kidney, whereas MR and mouse brains had
similar selenium levels. This effectwasnot explainedbyuniform
selenium deficiency because methionine sulfoxide reductase
activities were similar in mice and MR. However, glutathione
peroxidase activity was an order of magnitude lower inMR liver
and kidney than inmouse tissues. In addition,metabolic labeling
of MR cells with 75Se revealed a loss of the abundant glutathione
peroxidase 1 (GPx1) band,whereas other selenoproteinswere pre-
served. To characterize theMR selenoproteome, we sequenced its
liver transcriptome. Gene reconstruction revealed standard sel-
enoprotein sequences except for GPx1, which had an early stop
codon, and SelP, which had low selenocysteine content. When
expressed inHEK293cells,MRGPx1waspresent in lowlevels, and
its expression could be rescued neither by removing the early stop
codon nor by replacing its SECIS element. In addition, GPx1
mRNAwas present in lower levels inMR liver than inmouse liver.
To determine if GPx1 deficiency could account for the reduced
selenium content, we analyzed GPx1 knock-out mice and found
reduced selenium levels in their livers and kidneys. Thus, MR is
characterized by the reduced utilization of selenium due to a spe-
cific defect in GPx1 expression.
Naked mole rat (MR)2 (Heterocephalus glaber) is a unique
organism in the mammalian order rodentia. It is an attractive
model to study aging due to an extraordinary life span (more
than 28 years), which is unprecedented for rodents of similar
body size. Aging in MRs is characterized by very slow age-re-
lated declines that do not significantly affect breeding capacity,
social behavior, and daily activity (1–3). MR evolved a unique
eusocial lifestyle with strictly determined social roles and coop-
erative breeding within the colony. The anatomy of MR has
several specific features, which probably evolved as an adapta-
tion to living underground in oxygen-limiting conditions,
including underdevelopment of the visual system (4), skin
insensitivity (5), and the ability to tolerate low temperature (6)
and low oxygen levels (7). MRs are also characterized by a
decreasedmetabolic rate, which is associated with reduced lev-
els of thyroid hormones (3). One of the most remarkable fea-
tures of MR is that none of the autopsies of dead animals in
several colonies revealed cancer incidence (1). Moreover, pri-
mary fibroblasts derived from MR were sensitive to contact
inhibition (8), resistant to experimentally induced tumorigen-
esis, and unable to form xenograft tumors (9).
MR poses a challenge to the theories that link aging, cancer,
and oxidative stress. Because MR lives in low oxygen condi-
tions, it is expected to have low levels of oxidative stress. How-
ever, research showed that MR is characterized by significant
oxidative damage. Compared with mice, MRs have a lower
GSH/GSSG ratio, higher rate of lipid peroxidation, higher rate
of DNA oxidative damage, and higher protein carbonylation
(10). It was also demonstrated that MR proteins possess higher
levels of protein thiols, increased protein stability, increased
resistance to urea-induced denaturation, and elevated protea-
somal activity while also showing lower levels of protein ubiq-
uitination.Moreover, unlike themouse proteome, theMR pro-
teome did not show significant age-related susceptibility to
oxidation and ubiquitination (11). A separate study did not
detect age-related changes in the activities of antioxidant
enzymes, including Mn-superoxide dismutase, Cu/Zn-super-
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oxide dismutase, and catalase, and also observed low glutathi-
one peroxidase (GPx) activity (12).
Mammals have eight GPxs, including five selenoproteins.
GPx1 is the first identified and one of the best studied seleno-
proteins (13). This and other selenoprotein GPxs have seleno-
cysteine (Sec) residues in their active sites. GPx1 is a cytosolic
enzyme and the most abundant selenoprotein in mammals.
Other GPxs show different cellular localizations and/or tissue
and substrate specificities (14, 15). GPx1 is not an essential
enzyme (i.e.GPx1 knock-out mice are viable and fertile). How-
ever, GPx1 knock-out mice are more susceptible to oxidative
stress (16, 17) and viral myocardites (18). Expression of GPx1 is
decreased in prostate cancer and breast cancer cell lines (19) as
well as in themousemodel of liver cancer (20). A single nucleo-
tide polymorphism that changes Pro to Leu at codon 198 of
human GPx1 is associated with lung (21) and bladder (22)
cancers.
Currently, there is no information on the utilization of sele-
nium by MR; however, this is an essential trace element in
mammals, and its supplementation may be beneficial in cancer
chemoprevention (23). Selenium functions mostly through
incorporation into proteins in the form of Sec. Mice and
humans have 24 and 25 selenoprotein genes, respectively (24).
However, nothing is known about the composition of the MR
selenoproteome.
In this study, we observed low levels of selenium in MR tis-
sues. This observation led to the finding that the reduced utili-
zation of selenium by this organism was due to a specific defect
in GPx1 expression.
EXPERIMENTAL PROCEDURES
Animals—Animal experiments were approved by institu-
tional animal care and use committees at the University of Illi-
nois (Chicago, IL) andUniversity ofNebraska (Lincoln,NE). To
carry out inductively coupled plasma mass spectrometry (ICP-
MS) analyses, Western blotting, activity assays, and other anal-
yses, animals were sacrificed, and their tissues were frozen in
liquid nitrogen and stored until use. To prepare extracts, tissues
were homogenized in PBS supplementedwith a protease inhib-
itor mixture (Sigma). Cellular debris was removed by centrifu-
gation at 13,000 rpm for 15 min at 4 °C, and protein concentra-
tions were determined by the Bradford assay.
Tissue Samples for X-ray Fluorescence Microscopy (XFM)—
Tissues from C57BL/6 mice and MRs were extracted and pre-
pared at the same time to match preparation conditions. Mice
were fed a standard rodent chow diet. MRs were fed either a
sweet potato or carrot diet. Tissues from a 1-year-old MR were
compared with the corresponding samples of a 2-month-old
mouse to adjust for life span differences. All freshly extracted
tissues were washed in PBS and placed in 4% neutral buffered
formaldehyde in PBS for fixation. After 12 h, tissues were trans-
ferred to PBS, paraffin-embedded, and cut using a standard
microtome into 5-msections. Sections weremounted on silicon
nitride windows (2 2mm, 200-nm thickness; Silson, Blisworth,
UK). Light microscopy images were taken using a Leica DMXR
microscope (LeicaMicrosystems, Bannockburn, IL).
XFM—Trace elements inmouse andMR tissue samples were
imaged with XFM at the Advanced Photon Source, Argonne
National Laboratory (Argonne, IL). For each pixel, the full x-ray
fluorescence spectrumwas recorded using a single-element sil-
icon drift detector (Vortex EX, SII Nanotechnology,
Northridge, CA). Dwell time varied from 1.1 to 4 s/pixel. For
quantification, each set of experiments was followed by record-
ing x-ray fluorescence spectra of thin film standards NBS-1832
and NBS-1833 (National Bureau of Standards). X-ray fluores-
cence spectra for each sample were fitted and quantified using
data derived from standards. Image processing and analysis
were performed usingMAPS software (25). Each x-ray fluores-
cence image represents two-dimensional distribution of the
element.
Activity Assays—Total GPx activity was measured using a
GPx activity kit (Sigma) according to the manufacturer’s
instructions. Methionine-S-sulfoxide reductase (MsrA) and
methionine-R-sulfoxide (MsrB) activities were measured in an
HPLC assay as described (26). Briefly, 200 g of total protein
were added to a reaction mixture that was kept at 37 °C for 30
min in the presence of 20 mM DTT and either 200 M dabsyl-
methionine-S-sulfoxide (to assay for MsrA activity) or 200 M
dabsyl-methionine-R-sulfoxide (to assay for MsrB activity).
After stopping the reaction by adding 200 l of acetonitrile, it
was centrifuged at 4 °C for 15min at 13,000 rpm, and the super-
natant (50 l) was injected onto a C18 column (ZORBAX
Eclipse XDB-C18) to quantify the resulting dabsylated
methionine.
Splenocyte Isolation and 75Se Metabolic Labeling—After dis-
section, spleen was immediately transferred into ice-cold
DMEM and mashed through a 45-m cell strainer into the
50-ml tube. Cells were centrifuged at 800  g for 5 min. The
pellet was resuspended in 5 ml of ASK buffer (Invitrogen) and
incubated at room temperature for 5 min. Cells were then
diluted with DMEM and pelleted at 800 rpm for 5 min. The
resulting pellet was resuspended in 15 ml of DMEM supple-
mented with 10% fetal bovine serum (Invitrogen), antibiotic/
antimicotic (Invitrogen), 0.4 mM glutamine, and freshly neu-
tralized 75Se selenious acid (specific activity 1000 Ci/mmol,
final concentration in the medium 1 nM) and pooled into a
15-cm plate. After 24 h, cells were washed three times with
ice-cold PBS and lysed in CellLytic buffer (Sigma). Protein
extracts were analyzed by SDS-PAGE followed by
autoradiography.
Whole Transcriptome Sequencing and Assembly of Seleno-
protein Genes—Extraction of the total RNA fromMR liver was
carried out using an RNAqueous kit (Ambion) according to the
manufacturer’s instructions. DNA was removed by treatment
with DNase I (Ambion). Liver transcriptome was sequenced at
the University of Nebraska-Lincoln genomic facility on an Illu-
mina instrument. To assemble 35-bp reads into longer contigs,
three different strategies were used. First, mapping of reads to
reference sequence from mouse or guinea pig genomes was
performed using the MAQ package 0.7.1 (available from the
Sourceforge Web site). Second, SOAP package 1.03 (available
from the ShortOligonucleotideAnalysis PackageWeb site) was
used for de novo assembly of short reads. Finally, we employed
an in-house program thatwas optimized for assembling seleno-
protein genes and utilized the variety of information available
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fromMAQ and SOAP output as well as known sequences from
other rodents.
ICP-MS—Quantitative analyses of trace elements in animal
tissues were performed using ICP-MS. Freshly frozen mouse
and MR tissues were homogenized and sonicated in PBS with
Complete protease inhibitor mixture (Roche Applied Science)
(1 tablet in 50 ml of PBS). Samples were normalized to protein
content in each lysate, as determined using the Bradford Pro-
tein Kit (Bio-Rad). Samples were digested in 15% nitric acid,
15% hydrogen peroxide for 2 h at 70 °C. 50 ppb gallium were
added as an internal control to the digestion mix. After diges-
tion, samples were diluted 10 times with deionized water and
analyzed by ICP-MS. Elemental analysis was performed at the
University of Nebraska-Lincoln Spectroscopy Core Facility
using an Agilent Technologies ICP-MS model 7500ce (Santa
Clara, CA) and an Elemental Scientific Inc. (Omaha, NE) SC4
autosampler. Each sample was analyzed in triplicate. The car-
rier and make-up gas flows were 0.95 and 0.15 liter/min of
argon, respectively. The collision cell operated with 3.5 ml/min
H2 and 1.5 ml/min helium for reaction/collision mode. Dwell
times for all elements were 0.3 s except 78Se, for which the dwell
time was set at 0.9 s. Gallium (m/z 71) was added to all sam-
ples and standards as an internal standard at 50 ppb.
Expression Constructs for Mouse and MR GPx1 and Their
Mutants—Mouse and MR GPx1 cDNAs containing the
3-UTRs, including SECIS elements, were amplified by a two-
step PCR with primers that introduced Myc tag into ORFs.
Primers were designed as follows: mouse first round (CTCAG-
AGGAGGATCTCTGTGCTGCTCGGCTCTCCG and GCA-
TACTCTAGACTGATATTCAGCACTTTATTCTTAGTA-
GTGAAACC) and second round (CTCAGAGGAGGATCTC-
TGTGCTGGTCGTTTGGCCGCGGCC and GCATACTCT-
AGACTGATATTCAGCACTTTATTCTTAGTAGTGAA-
ACC); MR first round (CTCAGAGGAGGATCTCTGTGCTG-
GTCGTTTGGCCGCGGCC and GCATACTCTAGAACA-
CCCAGCACTTTATTAGAGGGTAATCATTTTGG) and
second round (GCATACTCTAGAACACCCAGCACTTTA-
TTAGAGGGTAATCATTTTGG and ATGACATCTCGAG-
ATGGAGCAGAAGCTCATCTCAGAGGAGGATCTC). The
PCRproductswere digestedwithXhoI andXba and ligated into
a similarly digested pCIneo vector. In the case of mouse GPx1,
an early premature stop codon was introduced using site-di-
rected mutagenesis with the QuikChange kit (Stratagene) and
primers GAAACCCTGCTGTCCTAGCAGTCTGGCAAC and
GTTGCCAGACTGCTAGGACAGCAGGGTTTC. The result-
ing mutant was designated as the M-short form. To rescue the
early stop codon in MR GPx1, we performed site-directed
mutagenesis with primers AAGCCCTACTCACTCAGGGG-
CGCGGCCCTG and CAGGGCCGCGCCCCTGAGTGAGT-
AGGGCTT, and the resulting mutant was designated as the
MR-long form. To obtain cysteine mutants of mouse and MR
GPx1, we used site-directed mutagenesis with primers TCGC-
GTCTCTCTGCGGCACCACGAT and ATCGTGGTGCCG-
CAGAGAGACGCGA for mouse GPx1 and GAATGTGGCA-
TCCCTCTGCGGCACCACGGTC and GACCGTGGTGCC-
GCAGAGGGATGCCACATTC for MR GPx1. To obtain a
pBudGE/GFP construct, EGFP was amplified from pEGPFN3
vector with primers ATGACAAGCTTATGGTGAGCAAGG-
GCGAGG and GGACATTCTAGATTACTTGTACAGCTC-
GTCC. The resulting PCR product was ligated into a similarly
digested pBudCE4.1 vector. Mouse and MR GPx1 mutants
were amplified from pCIneo constructs with primers GGTAC-
CATGGAGCAGAAGCTCATCTCAGAGG/GCATACGCA-
TACAGATCTCTGATATTCAGCACTTTATTCTTAG and
GGTACCATGGAGCAGAAGCTCATCTCAGAGG/AGAT-
CTACACCCAGCACTTTATTAGAGG, respectively, and
inserted into the second multiple cloning site of the
pBudCE4.1/GFP vector at Bglll/Kpnl restriction sites. Cys
mutants were amplified withGGTACCATGGAGCAGAAGC-
TCATCTCAGAGG and GCATACAGATCTTTAGGAGTT-
GCCAGACTGC (mouse) and GGTACCATGGAGCAGAAG-
CTCATCTCAGAGG and GCATACAGATCTCTATGCAG-
GGCCGCGCCCC (MR) and inserted into the vector without
the 3-UTR. To express mouse and MR GPx1 mutants in a ba-
cterial expression system, GPx1 mutants were amplified with
primers ATGCATCATATGGAGCAGAAGCTCATCTCA-
GAGG and GCATGCTCGAGTTAGGAGTTGCCAGA-
CTGC (mouse) and ATGCATCATATGTGTGCTGGTCGT-
TTGGCCG and GCATGCTCGAGCTATGCAGGGCCGCG-
CCCC (MR) and cloned into pET28a expression vector at NdeI
and XhoI sites.
To clonemouse andMRGPx1 into pSelExpress1,mouse and
MR GPx1 coding sequences were amplified with ATGAC-
ATAAGCTTATGGAGCAGAAGCTCATCTCAGAGG and
GCATACTCTAGATTAGGAGTTGCCAGACTGC (mouse)
and ATGACATAAGCTTATGGAGCAGAAGCTCATCTC-
AGAGG and GCATACTCTAGACTATGCAGGGCCGCG-
CCCC (MR) primers, digested with HindIII and XbaI restric-
tion endonucleases, and ligated into pSelExpress1 vector. To
swap mouse and MR 3-UTRs, we prepared the corresponding
constructs on the basis of the pBudCE4.1/GFP vector, which
expressedMyc-taggedGPx1 andGFP from separate sites in the
construct.
Cell Culture, Transfections,Metabolic Labeling, Immunopre-
cipitation, and Western Blot Analyses—HEK 293 and HeLa
cells were cultured in DMEM supplemented with 10% FBS, 100
units/ml penicillin, and 100 units/ml streptomycin. All trans-
fections were performed with Lipofectamine transfection rea-
gent (Invitrogen), according to the manufacturer’s manual.
Eighteen hours after transfection, medium was replaced with
one containing freshly neutralized 75Se selenious acid (specific
activity 1000 Ci/mmol, final concentration in the medium 1
nM). Cells were labeled for 24 h, and cellular extracts were ana-
lyzed by SDS-PAGE followed by autoradiography. For immu-
noprecipitation, HEK 293 cells were grown on 10-cm plates,
transfected with various GPx1 constructs, and metabolically
labeled with 75Se. Cells were resuspended in PBS, supple-
mented with protease inhibitor mixture (Sigma), and treated
with a tissue homogenizer. 600 g of total protein were sub-
jected to immunoprecipitationwith the ProteinG immunopre-
cipitation kit with mouse anti-Myc antibodies (Invitrogen),
according to themanufacturer’s instructions. ForWestern blot
analyses, samples were separated on 10% BisTris gels, trans-
ferred onto PVDFmembranes, and incubated withmouse anti-
Myc (Invitrogen) or anti-GFP (Sigma) antibodies.
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RNA Isolation and Quantitative PCR—To compare GPx1
expression levels in mice andMRs, total liver RNAwas isolated
by TRIzol extraction according to the manufacturer’s instruc-
tions. Genomic DNA was removed using a DNA removal kit
(Ambion). RNA concentration was measured spectrophoto-
metrically, and cDNAwas obtainedwith Superscript III reverse
transcriptase (Invitrogen) using the oligo(dT) primer. Real-
time PCR was performed using a Fast SYBR Green master mix
(Applied Biosystems). Primer sequences for the GPx1 expres-
sion analysis were as follows: mouse, CAGGAGAATGGCAA-
GAATGAAG and GAAGGTAAAGAGCGGGTGAG; MR,
GACACCAGGAAAACGCAAAGandAAGGTGAAGAGCG-
GATGTG (primers were based on the assembled transcrip-
tome sequences). GPx1 expression was normalized to that of
aldolase. Primers for aldolase expression were as follows:
mouse, GTGATCCTTTTCTACGAGACCC and ACCACA-
ATTCCCTTCTCCTTG; MR, AAGATGGGTGTGACTT-
TGGG and GGTACTAGCCCATTCTGTTGAC.
Additional Analyses ofmRNAs—RNAwas isolated from cells
transfected with various GPx1 constructs inserted into
pBudCE/GFP vector. It was then treated with RNase-free
DNase I (Fermentas). The resulting RNA samples were reverse
transcribedwith a SuperScript VILOcDNAsynthesis kit (Invit-
rogen). Quantitative PCR was performed using a Fast SYBR
Green Master Mix (Applied Biosystems). To distinguish
recombinant GPx1 from the endogenous form, we used the
direct primer specific for Myc-tag (TCATCTCAGAGGAG-
GATCTC) and reverse primers as follows: TGAGCCTTCT-
CACCATTCACTTCG (mouse) and CGAGCACTACCAG-
GCCTCTGG (MR). Expression of GPx1 mutants was
normalized to EGFP expressed from the same vector. Primers
for EGFP were as follows: TCAAGGACGACGGCAACTAC
and TTGTGCCCCAGGATGTTGCC.
Protein Isolation andActivity Assays—Recombinant cysteine
GPx1 mutants were expressed in BL21(DE3) cells (Novagen).
E. coli cells were transformed with various GPx1 constructs,
and the cells were grown until an OD of 0.6 at 600 nm. Protein
expression was induced overnight with 1 mM isopropyl 1-thio-
-D-galactopyranoside. Cells were harvested by centrifugation,
homogenized in 50 ml of PBS supplemented with Protease
Inhibitor Mixture EDTA-free (Roche Applied Science), and
sonicated on ice for 20 min. The suspension was centrifuged at
9000 rpm, and the resulting lysates were assayed for protein con-
centration and fractionated on a TALONTM column (Clontech).
Fractions containingGPx1mutantsweredialyzedagainstPBSand
subjected to activity assays using a GPx kit (Sigma).
RESULTS
Low Levels of Selenium inMR Tissues—We analyzed the lev-
els and distribution of selenium in various tissues of MR,
FIGURE 1.XFMand ICP-MSanalysis of selenium inmouse andMR tissues. Shownare XFM scans ofmouse andMR livers (A) and testes (B). Each element and
its maximum andminimum threshold values are given above each image in ng/cm2. The rainbow-colored scale bar relates to the signal intensity measured as
ng/cm2 in each spot, with dark pixels representing areas of low concentration and a gradient to bright pixels depicting increasing concentrations. A scale bar is
shown below the elemental maps. C, selenium was analyzed by ICP-MS in mouse and MR tissues. Values are means S.D. (error bars). Organs in which trace
elements were analyzed are shown below each panel.
Reduced SeleniumUtilization by NakedMole Rats
17008 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 19•MAY 13, 2011
 
 
H. glaber. Mouse tissues were used for comparison because
mice are rodents of similar size. Paraffin-embedded tissue sec-
tions were first imaged using synchrotron XFM. Selenium was
uniformly distributed in liver (Fig. 1A), heart, and lung tissues
in both organisms.Mouse testes are known to accumulate sele-
nium in elongating spermatids (28). However, such selenium
enrichment was not observed in MR testes (Fig. 1B). We esti-
mated selenium content in specific areas of MR and mouse
tissues (supplemental Fig. S1). Most MR tissues had consider-
ably lower selenium levels (30–75% lower). However, MR and
mouse brain samples had similar selenium contents. The brain
is known to retain selenium during deficiency (29).
To verify the XFM observation of low selenium in MR tis-
sues, we measured selenium in MR and mouse tissues using
ICP-MS. All MR tissues analyzed, except the brain, had lower
selenium levels than the correspondingmouse tissues (Fig. 1C).
The major selenium pool in mice is in the liver; however, MR
liver had low amounts of selenium. Thus, MR is characterized
by apparent selenium deficiency.
Low GPx Activity in MR Tissues—Because selenium mostly
occurs in the form of Sec in proteins, the low selenium in MR
tissues suggested a decreased expression of selenoproteins. To
test this hypothesis, we assayedmethionine sulfoxide reductase
and GPx activities. Mammals have three MsrBs, including the
selenoprotein MsrB1, which is the major MsrB in mouse liver
(30). Because it is responsible for MsrB activity in the cytosol
and nucleus (MsrB2 and MsrB3 are mitochondrial and endo-
plasmic reticulum proteins, respectively), it is probably the
main MsrB in all mammals. MsrB1 expression and activity (as
well as total MsrB activity) depend on dietary selenium. Mam-
mals also have a single MsrA, which is not a selenoprotein. We
found that bothMsrA andMsrB activities were similar in mice
and MRs (Fig. 2, A and B). Thus, low selenium in MR tissues
cannot be explained by uniform selenoprotein deficiency.
GPx1 is amajormammalianGPx, which is, likeMsrB1, easily
regulated by dietary selenium. We found extremely low GPx
activity in MR liver compared with the corresponding mouse
tissue (Fig. 2C). Low selenium in the liver correlated with low
GPx activity, which was suggestive of low GPx1 expression.
Sequencing and Analysis of the MR Liver Transcriptome—
Several rodent genomes were sequenced in recent years, but the
genome of MR is not available. To characterize selenoprotein
occurrence in MRs, we performed sequencing of the MR liver
transcriptome using Illumina technology. Overall, 25,011,515
36-bp-long reads were obtained and assembled into contigs. The
length distribution of assembled contigs is shown in Fig. 3A. The
best results were obtained using k-mer size of 23, wherein 395,038
contigs were generated, with 40,073 contigs longer than 100 bp
and 379 contigs exceeding 1000 bp.
Occurrence of selenoprotein genes was then examined, and
we detected 15 selenoprotein sequences. This analysis sug-
gested that the MR selenoproteome is similar to that of other
mammals. Schematic representation of the human selenopro-
teome (which contains 25 selenoproteins) is shown in Fig. 3B,
with MR orthologs identified in the current study highlighted.
The lack of some selenoprotein genes was probably due to
insufficient sequencing depth, but it also could be an indicator
of their low expression in MR liver. Overall, although selenium
levels and GPx activity were low in MR liver, this organ
expressed many selenoprotein mRNAs, and the majority of
these sequences had no unusual features (supplemental Figs.
S2–S16).
SelP is the only mammalian selenoprotein that contains
more than one Sec, and it has two SECIS elements in the
3-UTR. Mammalian SelPs generally have 10–15 Sec residues
(e.g. 10 Sec residues in human,mouse, and rat SelPs) (31). How-
ever, we found only 7 Sec residues in MR SelP (supplemental
Fig. S2). Together with SelP from Cavia porcellus, this is the
lowest Sec content of any vertebrate SelP.
In addition, we detected an unusual feature in MR GPx1: an
early stop codon present five codons upstream of the position
terminating GPx1 synthesis in other mammals (Fig. 3C and
supplemental Fig. S3). Thus, MR GPx1 was predicted to be 5
amino acids shorter than other mammalian GPx1s. SECIS ele-
ments in MR selenoprotein genes satisfied the requirements of
a canonical eukaryotic SECISmodel. Overall, it is likely that the
MR selenoproteome is not significantly different from that of
other mammals, with the exception of SelP and GPx1
sequences.
Low GPx1 Expression in MR—To test for GPx1 expression
levels, we isolated mouse and MR splenocytes and metaboli-
FIGURE 2.MRtissue extracts have lowGPx1expression andactivity. Total
MsrB (A), MsrA (B), and GPx (C) activities were measured in the indicated
mouse and MR tissues. D, primary splenocytes derived from MR and mice
were metabolically labeled with 75Se, and protein extracts were analyzed by
SDS-PAGE followed by autoradiography. The band corresponding to GPx1 is
shown with an arrow on the right. E, relative expression of GPx1 mRNA in MR
and mouse liver (*, p 0.05). Error bars, S.D.
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cally labeled the cells with 75Se, and they were analyzed by SDS-
PAGE followed by autoradiography (Fig. 2D). It appeared that
the GPx1 band was missing in MR splenocytes. To test if low
GPx1 expression and activity were due to a low mRNA expres-
sion, GPx1 mRNA levels were examined by real-time PCR.We
found that the MR GPx1 mRNA was expressed at much lower
levels than mouse GPx1 mRNA in the liver (Fig. 2E). Thus, the
low GPx1 activity was, at least in part, due to low GPx1 mRNA
levels.
Reduced Expression of MR GPx1 in Transfected Mammalian
Cells—An early stop codon in MR GPx1 could also contribute
to the low expression and activity of GPx1. To test this possi-
bility, we prepared constructs containing MR GPx1 with the
early UAG stop codon and the one where UAG was replaced
with CAG (encoding glutamine present in mouse GPx1 at this
position). As a control, we prepared mouse GPx1 and its
mutant, in which the CAG codon was changed to UAG (Fig.
4A). The constructs were transfected into HEK 293 cells,
which were then labeled with 75Se and analyzed for seleno-
protein expression patterns (Fig. 4C, top). The same mem-
brane was also subjected to Western blot analysis with anti-
Myc antibodies (Fig. 4C). To distinguish exogenous
selenoproteins from the endogenous GPx1, proteins were
immunoprecipitated with anti-Myc antibodies and analyzed
on a gel (Fig. 4C, bottom). Expression levels ofMRGPx1 were
much lower than that of mouse GPx1. Introduction of CAG
in place of UAG further decreased MR GPx1 expression. At
the same time, substitution of CAG with UAG in mouse
GPx1 did not decrease GPx1 expression.
In addition, mouse and MR GPx1 forms were cloned into a
pBudCE4.1 vector, containing GFP under the CMV promoter.
In further experiments, GFP was used as an internal control for
transfection and protein loading. Inhibition of proteasome in
HEK 293 cells did not rescueMRGPx1 expression (Fig. 4D). In
addition, real time PCR analysis revealed no difference between
mouse andMR GPx1 mRNA after transfection (Fig. 4B). Thus,
MR GPx1 expression was suppressed regardless of the early
stop codon.However, substitution of Secwith cysteine partially
rescued expression of MR GPx1 (Fig. 4E). These data suggest
that incorporation of Sec may limit GPx1 synthesis. We also
checked if the early stop codon in MR GPx1 affects peroxi-
dase activity of this enzyme by expressing Cys-containing
His-tagged MR and mouse GPx1s in bacteria. These mouse
and MR GPx1 proteins had similar activities (supplemental
Fig. S17). The data suggest that the early stop codon affects
neither expression nor activity of the enzyme and that the
low expression of MR GPx1 is due to a combination of low
mRNA levels and decreased Sec insertion. These two factors
FIGURE 3. Transcriptome analysis and characterization of the MR selenoproteome. A, length distribution of assembled contigs of the MR liver transcrip-
tome. B, selenoproteins identified inMR. The human selenoproteome is used as a reference to represent theMR selenoproteome. Selenoproteins identified by
sequencing the MR liver transcriptome are highlighted. The location of Sec residues is indicated by a red line. Seven Sec residues were found in SelP. GPx1 has
an early termination codon (see “Results”). C, schematic representation of MR GPx1 in comparison with mouse GPx1.
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may be linked (e.g. inefficient Sec insertion may destabilize
GPx1 mRNA).
SECIS Element in MR GPx1 Is Not Responsible for Low GPx1
Expression—Sec insertion includes recognition of the SECIS
element in the 3-UTR of selenoprotein mRNAs by SBP2 and
subsequent recruitment of additional factors, such as EFSec
and Sec-tRNA[Ser]Sec, which insert Sec in response to the UGA
codon. Efficiency of Sec incorporation may depend on addi-
tional features, such as the position of the UGA codon within
the ORF and the type of SECIS element (32–34). Alignment of
GPx1 SECIS elements revealed a nucleotide substitution in the
conserved SBP2 binding site (Fig. 5A). However, comparison of
MR (Fig. 5B) and mouse (Fig. 5C) SECIS elements in GPx1 did
not show unusual features in the MR SECIS element, suggest-
ing that the predicted structuremay support Sec incorporation.
To directly test if theMRGPx1 SECIS element is responsible
for the low GPx1 expression, we cloned coding sequences of
mouse and MR GPx1s into pSelExpress1 vector containing a
highly efficient eukaryotic SECIS element (27). Analysis of
these expression constructs (containing the same SECIS ele-
ment) by metabolic 75Se labeling of transfected HEK 293 cells
showed that the MR GPx1 was still expressed at a low level
compared with mouse GPx1 (Fig. 5D). To further examine the
role of SECIS elements as well as the entire 3-UTRs in GPx1
expression, we prepared constructs that swapped the 3-UTRs
between mouse and MR GPx1s. These constructs were
expressed inHEK 293 cells, followed by 75Se labeling andWest-
ern blot analysis (Fig. 5E). Substitution of theMRGPx1 3-UTR
with that of themouse did not increaseMRGPx1 expression; in
addition, replacement of the mouse GPx1 3-UTR with that of
the MR did not decrease the expression of mouse GPx1. Thus,
neither the SECIS element nor the 3-UTRwere responsible for
the reduced MR GPx1 expression. It is an attractive possibility
that the overall GPx1 mRNA structure modulates the rate of
Sec incorporation.
Absence of GPx1Decreases Selenium Levels inMice—GPx1 is
the most abundant selenoprotein in mouse liver and kidney.
We tested if removal of this protein could affect selenium levels
FIGURE 4. GPx1 is poorly expressed in mammalian cells. A, schematic representation of MR and mouse GPx1 mutant constructs. Positions of Sec and
glutamine (CAG) codons, the stop signal (TAG), and the SECIS element in the 3-UTR are shown. B, mRNA levelswere assessed by real-time PCR and normalized
to GFP expressed from the same vector. Results are given S.D. (error bars). C, MR andmouse Myc-GPx1 constructs were transfected into HEK 293 cells. Cells
were labeledwith 75Se, followed by SDS-PAGE and autoradiography (top). Migration of ectopically expressed GPx1 is shown on the left. The same lysates were
probed with anti-Myc and anti--actin antibodies (two bottom panels). Myc-GPx1mutants were also immunoprecipitated with anti-Myc antibodies, followed
by PhosphorImager analysis of the 75Se-labeled GPx1.D, mouse andMR constructs were transfected into HEK 293 cells followed by treatment of cells with 10
MMG132 for 12 h. Cells were labeled with 75Se, followed by protein analysis by SDS-PAGE and autoradiography (top). The samemembranewas stainedwith
Myc andGFP antibodies. E, expression ofmouse andMR cysteinemutants of GPx1 inHEK 293 cells was analyzed byWestern blotting. IP, immunoprecipitation;
WB, Western blotting.
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in tissues by examining WT and GPx1 knock-out mice. Sele-
nium levels inGPx1 knock-outmicewere almost twice as low as
those in WT livers (Fig. 6) (p  0.00387) and kidneys (p 
0.0409). However, in tissues characterized by lower GPx1 lev-
els, such as spleen, heart, lung, and brain, selenium levels were
not affected by GPx1 knock-out. Thus, the absence of GPx1
could indeed be responsible for the reduced selenium use by
MRs.
GPx1 Expression in Long Lived Rodents—To examine if the
aberrant expression of MR GPx1 has evolutionary aspects, we
analyzed its levels in primary skin fibroblasts derived from long
lived rodents, including white footed mouse, chipmunk, vole,
single fox squirrel, beaver, and porcupine, and also examined
fibroblasts from another long lived mammal, the little brown
bat (35). Cells were metabolically labeled with 75Se, and pro-
teinswere analyzed by SDS-PAGE followedby autoradiography
(supplemental Fig. S18A). HEK 293 cells were used as a positive
control, and mouse embryonic fibroblasts were derived from
GPx1 knock-out mice as a negative control. All analyzed spe-
cies, except for the porcupine, had a strong band corresponding
to GPx1. In the case of the porcupine, we observed a weak 75Se
signal in the GPx1 position and a stronger band that migrated
FIGURE 5. SECIS element does not decrease GPx1 expression level. A, alignment of mammalian GPx1 SECIS elements. Nucleotides critical for the SECIS
function are underlined. B, MR GPx1 SECIS element as predicted by SECISearch. Functional sites are shown in boldface type (24). C, mouse GPx1 SECIS element.
Functional sites are shown in boldface type.D, mouse andMR GPx1 coding sequences were cloned into pSelExpress1 containing an efficient eukaryotic SECIS
element and expressed in HEK 293 cells. Cells were labeled with 75Se, followed by SDS-PAGE, autoradiography, and Western blotting with Myc antibodies.
Coomassie staining is a loading control. E, coding sequences of mouse GPx1 containing the MR GPx1 3-UTR (M-long-MR SECIS) and coding sequence of MR
GPx1containingmouseGPx13-UTR (MR-short-MSECIS)wereexpressed inHEK293cells. Cellswere labeledwith 75Se, followedbySDS-PAGE, autoradiography,
and Western blotting with Myc and GFP antibodies.WB, Western blot.
FIGURE 6. Reduction in selenium levels in tissues of GPx1 KO mice. Sele-
nium was determined by ICP-MS in tissues from wild type (WT) and GPx1
knock-out (KO) mice. Values are means  S.D. (error bars). Organs in which
seleniumwas analyzedare shownbeloweachpanel (**,p0.005; *,p0.05).
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faster than GPx1. Sequence analysis of GPx1 in these rodents
should await the availability of their genome sequences. How-
ever, examination of the phylogenetic tree indicated that MR
and porcupine share a common ancestor (supplemental Fig.
S18B), whereas other examined mammals are more distant.
Thus, it appears that the defect in GPx1 expression may not be
limited to MR and may occur in a subset of rodents.
DISCUSSION
GPx1 is an abundant glutathione peroxidase in mammals. It
plays an important role in the protection of cells from oxidative
stress by reducing hydrogen peroxide with glutathione. Sur-
prisingly, we found that GPx1 is essentially absent in MR tis-
sues, whereas other selenoproteins are expressed at normal lev-
els and/or are enzymatically competent. Sequencing and
analysis of the MR liver transcriptome detected GPx1 mRNA,
but it was present at low levels and had an early termination
codon. Further analyses revealed that the low expression was
probably due to a combination of low mRNA levels and
decreased insertion of Sec rather than due to compromised
GPx1 activity caused by premature termination.
It was reported that GPx1 is the most abundant liver seleno-
protein. In rat liver, it accounts for 63% of the total selenium
(36). Selenium deficiency induces rapid degradation of GPx1
mRNA (and several other selenoprotein mRNAs), whereas the
expression levels of several additional selenoproteins are pre-
served under these conditions (37). GPx1 was proposed as a
biomarker of selenium utilization because its activity is very
sensitive to selenium dietary status. It was also suggested that
GPx1 is a “selenium buffer,” wherein this enzyme stores sele-
nium and provides this element for biosynthesis of selenopro-
teins during selenium deficiency (38). On the other hand, GPx1
knock-out does not affect expression of other selenoproteins
(39, 40). This enzyme is also not essential. GPx1 knock-out
animals are viable; however, they are more susceptible to oxi-
dative stress and show defects in redox signaling (41). These
data correlate with previously reported increases in oxidative
stress parameters inMR, including a lowGSH/GSSG ratio, high
rate of DNA oxidative damage, and increased protein carbony-
lation and lipid peroxidation (10).Moreover, bothGPx1 knock-
out mice and MRs showed abnormal blood glucose regulation
(39, 40). These mice had a normal fasting glucose but reduced
blood insulin levels (41, 42). However, unlike GPx1 knock-out
mice,MR also showed abnormal glucose tolerance (glucose lev-
els remained elevated for prolonged periods of time) and insu-
lin sensitivity (glucose levels immediately decreased upon insu-
lin administration and remained low for prolonged periods of
time) (10, 43). In addition, GPx1 knock-out mice had reduced
islet -cell mass in pancreatic tissue (42), whereas MR had dif-
ferent abundances of the four distinct types of islet cells.
Although the abnormal glucose regulation may be relevant to
MRadaptation to its specific lifestyle, it could be, at least in part,
due to an abnormal GPx1 function.
Selenium levels in animal tissues vary depending on many
factors, including the requirements of the organism for this
trace element and the diet. Numerous studies have reported on
the role of dietary selenium in human health. For example, sele-
nium deficiency may cause endemic cardiomyopathy (Keshan
disease), liver degeneration observed in rats and pigs, andwhite
muscle disease in ruminants and turkeys (23, 44). None of the
selenium deficiency-induced pathologies have been reported
for MR. In this regard, it is particularly interesting that MRs
have never been observed to develop cancer (2). We compared
trace element profiles in control and GPx1 knock-out mice and
found a significant decrease of tissue selenium levels in liver and
kidney. Somewhat similar differences in selenium levels were
observed between mouse and MR. GPx1 is the most abundant
selenoprotein, especially in liver and kidney, and the GPx1
knock-out data suggest that this protein accounts for approxi-
mately half of selenium in these organs.
We also observed significant differences in selenium in
spleen, lungs, and testes (these tissues depend on selenium pro-
vided by SelP). This selenoprotein is the only mammalian pro-
tein that contains multiple Sec residues (31). Previously, we
suggested that the number of Sec residues in SelPmight be used
as an indirect genetic marker of selenium utilization (45). In
rodents and primates, the Sec content of SelP is almost twice as
low as in aquatic vertebrates. Comparison of rodent SelPs
shows that C. porcellus and MR SelPs have 7 Sec residues,
which is the lowest number of SelP Sec residues in vertebrates.
MR, porcupine, andC. porcellus are closer to each other and are
more distant from other rodents, such asmice, rats, and rabbits
(46). Our analysis of GPx1 expression suggested a decreased
GPx1 expression in MR and porcupine, and previous research
revealed low GPx1 activity in C. porcellus (47). Overall, these
data suggest a possible loss of GPx1 function in this specific
group of rodents and, as a consequence, a reduced requirement
for selenium by these organisms. It is remarkable that such an
important selenoprotein is compromised in these animals,
which survived for tens of millions of years essentially without
GPx1.
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Supplementary Information 
 
 
Figure S1. Quantification of Se in mouse and MR tissues. Se was quantified in XFM scans of similar 
areas of mouse and MR tissues. At least 3 representative XFM images were used for each quantification. 
Organs in which trace elements were analyzed are shown below each panel. 
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Homo sapiens             1 MWRSLGLALALCLLPSGGTESQDQSSLCKQPPAWSIRDQDPMLNSNGSVTVVALLQASUY 
Sus scrofa               1 MWRGLGLALALCLLSWGGTESQGKSSFCEQPPGWSIKDQDPMLNSYGSVTVVALLQASUY 
Canis familiaris         1 MWRSLGLALALCLLPWGGAESQGQSSFCKQPPAWSIRDQNPMLNSSGSVTVVALLQASUY 
Mus musculus             1 MWRSLGLALALCLLPYGGAESQGQSSACYKAPEWYIGDQNPMLNSEGKVTVVALLQASUY 
Rattus norvegicus        1 MWRSLGLALALCLLPYGGAESQGQSPACKQAPPWNIGDQNPMLNSEGTVTVVALLQASUY 
Heterocephalus glaber    1 MWRSLGLALVLCLLPGGGAGSQSQSSFCKQPPAWSIRGQNPMLNATGTVTVVALLQASUY 
 
 
Homo sapiens            61 LCILQASKLEDLRVKLKKEGYSNISYIVVNHQGISSRLKYTHLKNKVSEHIPVYQQEENQ 
Sus scrofa              61 LCILQASRLEDLRVKLEKEGYSNISYIVVNHQGIASQLKYVYLKSKVSEHIPVYQQEENQ 
Canis familiaris        61 LCILQASRLEDLRVKLEKEGFLNISYVVVNHQGLSSQLKYMYLKNKVSEHIPVYQQEENQ 
Mus musculus            61 LCLLQASRLEDLRIKLESQGYFNISYIVVNHQGSPSQLKHSHLKKQVSEHIAVYRQEEDG 
Rattus norvegicus       61 LCLLQASRLEDLRIKLENQGYFNISYIVVNHQGSPSQLKHAHLKKQVSDHIAVYRQDEHQ 
Heterocephalus glaber   61 LCILQASRFEDLRVKLEKEGYSNISFVIVNHQGSNSRLKYIQLKNQVSDHIPVYQQEEQQ 
 
 
Homo sapiens           121 TDVWTLLNGSKDDFLIYDRCGRLVYHLGLPFSFLTFPYVEEAIKIAYCEKKCGNCSLTTL 
Sus scrofa             121 TDVWTLLNGNKDDFLIYDRCGLLVYHLGLPYSFLTFPYVEEAIKTVYCENKCGNCSLKTL 
Canis familiaris       121 TDVWTLLNGKKDDFLIYDRCGRLVYHLGLPYSFLTFPYVEEAIKRAYCEEKCGNCSLTVL 
Mus musculus           121 IDVWTLLNGNKDDFLIYDRCGRLVYHLGLPYSFLTFPYVEEAIKIAYCEERCGNCNLTSL 
Rattus norvegicus      121 TDVWTLLNGNKDDFLIYDRCGRLVYHLGLPYSFLTFPYVEEAIKIAYCEKRCGNCSFTSL 
Heterocephalus glaber  121 TDVWSLLNGNKDDFLIYDRCGRLVYHLGLPYSFLSFPYVEEAIKIAYCEEKCGNCSLRTL 
 
 
Homo sapiens           181 KDEDFCKRVSLATVDKTVETPSP------HYHHEHHHNHGHQH----LGSSELSENQQPG 
Sus scrofa             181 KDEDFCKNVYLATEEKTTEAPQPHHHHDHHHHRHHHHHHGHQH----LGNGHLSEHPKPE 
Canis familiaris       181 EDEEVCKMVSSGTVESTTEAPQP-HPHDHHLHHHHHHHHKHWHRLMPHGNDELSENQQPE 
Mus musculus           181 EDEDFCKNVTSATANKTAEPSEA------HSHHKHHNKHGQEH----LGSSKPSENQQPG 
Rattus norvegicus      181 EDEAFCKNVSSATASKTTEPSEE------HNHHKHHDKHGHEH----LGSSKPSENQQPG 
Heterocephalus glaber  181 EDEDFCKNVSLATVEKTAEAPHP--------HNKQHHKHGHQH----LGGSELSDNKQSA 
 
 
Homo sapiens           231 APNTPTHPAPPGLHHHHK---HKGQHRQGHPENRDMPASEDLQDL---QKKLCRKRCINQ 
Sus scrofa             237 APDAPEQPPPSGLHHHHG---HKGHQRQGHSENUDMPAGSESLQLSLPQKKLURRGCISQ 
Canis familiaris       240 EPDVSEHPAPQGLHRHHK---HKDHQRQGHPDNUDMPAGSESLQLSVPQNQLURKGCRNQ 
Mus musculus           231 PS--ETTLPPSGLHHHHR---HRGQHRQGHLESUDTTAS-EGLHLSLAQRKLURRGCINQ 
Rattus norvegicus      231 ALDVETSLPPSGLHHHHHHHKHKGQHRQGHLESUDMGAS-EGLQLSLAQRKLURRGCINQ 
Heterocephalus glaber  229 APD-NPVLSPLGHHHHHEL-MPKGQQGQGHSESUFMSES-EALQLSLVRRKLCQKGCKNQ 
 
 
Homo sapiens           285 LLCKLPTDSELAPRSUCCHCRHLIFEKTGSAITUQCKENLPSLCSUQGLRAEENITESCQ 
Sus scrofa             294 LLCKFPKNSESALRSUCUHCRHLIFEKTESAVTUQCGENLPSLCSUQGLLAEENVIESUQ 
Canis familiaris       297 LLCKLPRDSGLAPSSUCUHURHLIFEKTGSAITUQCKETLPSLCSUQGLWAEENVIESUQ 
Mus musculus           285 LLCKLSKESEAAPSSCCCHCRHLIFEKSGSAIAUQCUENLPSLCSUQGLFAEEKVTESCQ 
Rattus norvegicus      290 LLCKLSEESGAATSSCCCHCRHLIFEKSGSAITUQCAENLPSLCSUQGLFAEEKVIESCQ 
Heterocephalus glaber  286 LLCKFPTDSQLAPSSCCCYCRHLVFGRRGSAVTCQCAENLPSLCSCQGDWAGEKVIESCQ 
 
 
Homo sapiens           345 URLPPAAUQISQQLIPTEASASURUKNQAKKUEUPSN 
Sus scrofa             354 URLPPAAUQASQQLNPAEASTKUSUKNKAGRUKUPSN 
Canis familiaris       357 URWPPAAUQASQQLRPTEASTNUSUKYKTKMUKULTY 
Mus musculus           345 CRSPPAAU-QNQPMNPMEANPNUSUDNQTRKUKUHSN 
Rattus norvegicus      350 CRSPPAAU-HSQHVSPTEASPNUSUNNKTKKUKUNLN 
Heterocephalus glaber  346 CRLPPAAUQINQQK-PTETNRDUSUNNRAQKUKUPSN 
 
 
 
Figure S2. Protein sequence alignment of SelP. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (AAH58919.1); Canis familiaris 
(NP_001108590.1); Sus scrofa (NP_001128295.1); Mus musculus (AAH01991.2); and Rattus norvegicus 
(NP_062065.2). Selenocysteine residues are highlighted in red, and cysteines in the positions corresponding 
to selenocysteine are shown in blue. 
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                                                                            * 
Homo sapiens           1 MCAARLAAAAAAAQ---SVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYT 
Sus scrofa             1 MCAAQRSAAALAAVAPRSVYAFSARPLAGGEPISLGSLRGKVLLIENVASLUGTTVRDYT 
Canis familiaris       1 MCAAALAAAAVAAAP-RSVYAFSARPLAGGEPMSLGSLRGKVLLIENVASLUGTTVRDYT 
Mus musculus           1 MCAARLSAAAQSTV-----YAFSARPLTGGEPVSLGSLRGKVLLIENVASLUGTTIRDYT 
Rattus norvegicus      1 MSAARLSAVAQSTV-----YAFSARPLAREEPVSLGSLRGKVLLIENVASLUGTTTRDYT 
Cavia porcellus        1 MCAARLVAAAQATV-----YSFSARPLAGGEPLNFGSLRGKVLLIENVASLUGTTVRDFT 
Heterocephalus glaber  1 MCAGRLAAAAQATV-----YSFSARPLTGGEPLSLGSLRGKVLLIENVASLUGTTVRDFT 
 
Homo sapiens           58 QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEV 
Sus scrofa             61 QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNGEILNCLKYVRPGGGFEPNFMLFEKCEV 
Canis familiaris       59 QMNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFTLFEKCEV 
Mus musculus           56 EMNDLQKRLGPRGLVVLGFPCNQFGHQENGKNEEILNSLKYVRPGGGFEPNFTLFEKCEV 
Rattus norvegicus      56 EMNDLQKRLGPRGLVVLGFPCNQFGHQENGKNEEILNSLKYVRPGGGFEPNFTLFEKCEV 
Cavia porcellus        55 QMNDLQARLGHKGLVVLGFPCNQFGHQENAKNEEILHSLKYVRPGGGFEPNFTLFEKCEV 
Heterocephalus glaber  56 QMNQLQARFGPRGLVVLGFPCNQFGHQENAKNEEILHLLKYVRPGGGFEPNFTLFEKCEV 
 
Homo sapiens          118 NGAGAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLR 
Sus scrofa            121 NGANAHPLFAFLREALPTPSDDATALMTDPKFITWSPVCRNDIAWNFEKFLVGPDGVPLR 
Canis familiaris      119 NGAQAHPLFAFLRESLPAPSDDTTALMTDPKFITWSPVCRNDVAWNFEKFLVGPDGVPVR 
Mus musculus          116 NGEKAHPLFTFLRNALPTPSDDPTALMTDPKYIIWSPVCRNDIAWNFEKFLVGPDGVPVR 
Rattus norvegicus     116 NGEKAHPLFTFLRNALPAPSDDPTALMTDPKYIIWSPVSRNDISWNFEKFLVGPDGVPVR 
Cavia porcellus       115 NGAKAHPLFTFLREALPAPSDDPIALMTDPKFIIWSPVCRNDVSWNFEKFLVGPDGVPVR 
Heterocephalus glaber 116 NGAKAHPLFTFLREALPAPSDEPTALMTDPKFIIWSPVCRNDVAWNFEKFLVGPDGVPVR 
 
Homo sapiens          178 RYSRRFQTIDIEPDIEALLSQGPSCA 
Sus scrofa            181 RYSRRFLTIDIEPDIEALLSQEPSSA 
Canis familiaris      179 RYSRRFPTIDIEPDIEALLSQGPSCA 
Mus musculus          176 RYSRRFRTIDIEPDIETLLSQQSGNS 
Rattus norvegicus     176 RYTRRFRTIDIEPDIEALLSKQSSNP 
Cavia porcellus       175 RYSRRFPTIDIEPDIEALLSQGSGPA 
Heterocephalus glaber 176 RYSRRFPTIDIEPDIKALLT& 
 
Figure S3. Protein sequence alignment of GPx1. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_000572.2); Sus scrofa (NP_999366.1); 
Canis familiaris (NP_001108591); Rattus norvegicus (AAB95647.2), Mus musculus (CAA27558) and 
Cavia porcellus (AAKN02012894.1). The selenocysteine residue is highlighted in red and indicated by an 
asterisk. The early stop codon in the MR sequence is also highlighted in red. 
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                                                                        * 
Homo sapiens             1 -----MAFIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ 
Sus scrofa               1 -----MAYIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ 
Canis familiaris         1 -----MAYIAKSFYDLSAISLDG-EKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQ 
Oryctolagus cuniculus    1 MCAARMAAAAQSVYSFSAHPLAGGEPVNLGSLRGKVLLIENVASLUGTTVRDYTQMNELQ 
Mus musculus             1 -----MAYIAKSFYDLSAVGLDG-EKIDFNTFRGRAVLIENVASLUGTTTRDYNQLNELQ 
Rattus norvegicus        1 -----MAYIAKSFYDLSAIGLDG-EKIDFNTFRGRAVLIENVASLUGTTTRDYTQLNELQ 
Heterocephalus glaber    1 -------------------ALDG-EKVDFNTFRGRVVLIENVASLUGTTTRDFTQLNELQ 
 
Homo sapiens            55 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFTLVQKCEVNGQNEH 
Sus scrofa              55 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFTLIQKCDVNGQNEH 
Canis familiaris        55 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFTLVQKCEVNGQNEH 
Oryctolagus cuniculus   61 ERLGPRALVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFQKCEVNGAKAS 
Mus musculus            55 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFSLTQKCDVNGQNEH 
Rattus norvegicus       55 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGFQPTFSLTQKCDVNGQNQH 
Heterocephalus glaber   41 CRF-PRRLVVLGFPCNQFGHQENCQNEEILNSLKYVRPGSGFQPTFTLVQKCEVNGQNEH 
 
Homo sapiens           114 PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTF 
Sus scrofa             114 PVFAYLKDKLPYPYDDPFSLMTDPKFIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRTF 
Canis familiaris       114 PVFAYLKDKLPYPYDDPLSLMTDPKFIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTF 
Oryctolagus cuniculus  121 PLFAFLREALPPPSDDPTALMTDPKFITWCPVCRNDVSWSFEKFLVGPDGVPVRRYSRRF 
Mus musculus           114 PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRSF 
Rattus norvegicus      114 PVFAYLKDKLPYPYDDPFSLMTDPKLIIWSPVRRSDVSWNFEKFLIGPEGEPFRRYSRTF 
Heterocephalus glaber  100 PVFAYLKDKLPYPYDDPFSLMTDPKLIMWSPVRRNDVAWNFEKFLVGPDGVPVRRYSRRF 
 
Homo sapiens           174 PTINIEPDIKRLLKVAI--- 
Sus scrofa             174 PTINIEPDIKRLLKVAI--- 
Canis familiaris       174 PTINIEPDIKRLLKVAI--- 
Mus musculus           174 QTINIEPDIKRLLKVAI--- 
Oryctolagus cuniculus  181 PTIDIEPDIQALLSKGSGGA 
Rattus norvegicus      174 QTINIEPDIKRLLKVAI--- 
Heterocephalus glaber  160 PTIDIEPDIKALL------- 
 
 
 
Figure S4. Protein sequence alignment of GPx2. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_002074.2); Sus scrofa (NP_001108608.1); 
Canis familiaris (NP_001108607.1); Oryctolagus cuniculus (NP_001078913.1); Rattus norvegicus 
(NP_899653.2) and Mus musculus (NP_109602.2). The MR sequence is incomplete. The selenocysteine 
residue is highlighted in red and indicated by an asterisk. 
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Homo sapiens             1 MSLGRLCRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYR 
Homo sapiens             1 MSFSRLFRLLKPTLLCGTLAVPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYR 
Mus musculus             1 MSWGRLSRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVCLDKYR 
Rattus norvegicus        1 MSWGRLSRLLKPALLCGALAVPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVCLDKYR 
Cavia porcellus          1 ---------------------------MCASRDDWRCARSMHEFATKDIDGHMVCLDKYR 
Heterocephalus glaber    1 ----RLSRLLKPALLCGALTAPGLAGTMCASRDDWRSAHSMHEFSAKDIDGHMVSLDKYK 
 
                                       * 
Homo sapiens            61 GFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFA 
Sus scrofa              61 GYVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSDAEIKEFA 
Mus musculus            61 GFVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA 
Rattus norvegicus       61 GCVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA 
Cavia porcellus         34 GCVCIVTNVASQUGKTDVNYTQLVDLHARYAECGLRILAFPCNQFGRQEPGSNQEIKEFA 
Heterocephalus glaber   57 GFVCIVTNVASQUGKTEVNYTQFVDLHARYAECGLCILAFPCNQFGKQEPGTNEEVKHFA 
 
Homo sapiens           121 AGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRY 
Sus scrofa             121 AGYNVKFDMFSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY 
Mus musculus           121 AGYNVKFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY 
Rattus norvegicus      121 AGYNVRFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY 
Cavia porcellus         94 AGYNVRFDMYSKICVNGDDAHPLWKWMKVQPKGRGMLGNAIKWNFTKFLIDKNGCVVKRY 
Heterocephalus glaber  117 AGYNVKFDMFSKICVNGDDAHPLWKWMKVQPKGKGMLGNAIKWNFTKFLIDKNGCVVKRY 
 
Homo sapiens           181 GPMEEPLVIEKDLPHYF 
Sus scrofa             181 GPMEEPQVIEKDLPCYL 
Mus musculus           181 GPMEEPQVIEKDLPCYL 
Rattus norvegicus      181 GPMEEPQVIEKDLPCYL 
Cavia porcellus        154 GPMEEPQVIEKDLPCYL 
Heterocephalus glaber  177 GPMEEPLVIEKDLTCYL 
 
 
Figure S5. Protein sequence alignment of GPx4. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_002076.2); Sus scrofa (NP_999572.1); 
Mus musculus (NP_032188.3); Rattus norvegicus (AAC52503.2); and Cavia porcellus (BAA92142.1). MR 
and C. porcellus sequences are incomplete. The selenocysteine residue is highlighted in red and indicated 
by an asterisk. 
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                                      * 
Homo_sapiens            1 MALAVRVVYCGAUGYKSKYLQLKKKLEDEFPGRLDICGEGTPQATGFFEVMVAGKLIHSK 
Sus_scrofa              1 MGVAVRVVYCGAUGYKSKYLQLKKKLEDEFPGRLDICGEGTPQVTGFFEVLVAGKLVHSK 
Canis_familiaris        1 MALAVRVVYCGAUGYKSKYLQLKKKLEDEFPGCLDICGEGTPQATGFFEVTVAGKLVHSK 
Mus_musculus            1 MALAVRVVYCGAUGYKPKYLQLKEKLEHEFPGCLDICGEGTPQVTGFFEVTVAGKLVHSK 
Rattus_norvegicus       1 MALAVRVVYCGAUGYKPKYLQLKEKLEHEFPGCLDICGEGTPQVTGFFEVTVAGKLVHSK 
Heterocephalus glaber   1 MALSVRVVYCGAUGYKPKYLQLKEKLEDEFPGCLDICGEGTPQSTGFFEVTIAGKLVHSK 
 
Homo_sapiens           61 KKGDGYVDTESKFLKLVAAIKAALAQG- 
Sus_scrofa             61 KGGDGYVDTESKFLKLVAAIKAALAQG- 
Canis_familiaris       61 KRGDGYVDTESKFLRLVAAIKTALAQG- 
Mus_musculus           61 KRGDGYVDTESKFRKLVTAIKAALAQCQ 
Rattus_norvegicus      61 KRGDGYVDTESKFRKLVTAIKAALAQCQ 
Heterocephalus glaber  61 KGGDGFVDTNSKFRKLVAAIKAALAQG- 
 
 
 
Figure S6. Protein sequence alignment of SelW. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_003000.1); Sus scrofa (NP_999142.1); 
Canis familiaris (NP_001108484.1); Mus musculus (NP_033182.1); and Rattus norvegicus (NP_037159.3). 
The selenocysteine residue is highlighted in red and indicated by an asterisk. 
 
 
                                                                      * 
Homo sapiens             1 MAPRGRKRKAEAAVVAVAEKREKLANGGEGMEEATVVIEHCTSURVYGRNAAALSQALRL 
Sus scrofa               1 MASRGRKRKAETALGAAAEKQETPASGRKGMEEASVVIEHCTSURVYGRNAAALSQALRL 
Canis familiaris         1 MASRGRKRKAEAAGVAAAEKREKPASGRKAVEEATVVIEHCTSURVYGRNAAALSQALRL 
Mus musculus             1 MAPHGRKRKAGAAPMETVDKREKLAEG------ATVVIEHCTSURVYGRHAAALSQALQL 
Rattus norvegicus        1 MAPLGRKRKAGAAPIESADKREKLAEG------AAVVIEHCTSURVYGRHAAALSQALQL 
Heterocephalus glaber    1 MAPRGRKRKAEASEVGSAGKREELADSGAGAAEVQVVIEHCTSURVYARQAAALSQALRE 
 
Homo sapiens            61 EAPELPVKVNPTKPRRGSFEVTLLRPDGSSAELWTGIKKGPPRKLKFPEPQEVVEELKKY 
Sus scrofa              61 EAPELPVRVNPTKPRRGSFEVTLMRPDGSSAELWTGIKKGPPRKLKFPEPQEVVEELKKY 
Canis familiaris        61 ETPELPVEVNPAKPRRGSFEVTLLRPDGSSVELWTGIKKGPPRKLKFPEPQEVVKALKQH 
Mus musculus            55 EAPELPVQVNPSKPRRGSFEVTLLRSDNSRVELWTGIKKGPPRKLKFPEPQEVVEELKKY 
Rattus norvegicus       55 EAPEISVQVNRSKPRRGSFEVTLLRPDNSRVELWTGIKKGPPRKLKFPEPQEMVEELKKY 
Heterocephalus glaber   61 AAPQLAVALNPARPRRGSFEVTLRRADGSSAPLWTGIKKGPPRKLKFPEPQAVVEELSKH 
 
Homo sapiens           121 LS 
Sus scrofa             121 LS 
Canis familiaris       121 LS 
Mus musculus           115 LS 
Rattus norvegicus      115 LS 
Heterocephalus glaber  121 LP 
 
 
Figure S7. Protein sequence alignment of SelH. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_734467.1); Sus scrofa (NP_001171877.1); 
Mus musculus (NP_001028338.1); Rattus norvegicus (NP_001108411.1); and Canis familiaris 
(NP_001157978.1). The selenocysteine residue is highlighted in red and indicated by an asterisk. 
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Homo_sapiens             1 MAAGPSGCLVPAFGLRLLLATVLQAVSAFGAEFSSEACRELGFSSNLLCSSCDLLGQFNL 
Sus_scrofa               1 MAAEPGGWLGPALGLRLLLATALQMVSAFGAEFSSESCRELGFSSNLLCGSCDLLGQFDL 
Canis_familiaris         1 MAPGPGGRLGPALRLRLLLAAVLQAVSTFGAEFSSEACRELGFSSNLLCSSCDLLGQFNL 
Mus_musculus             1 MAAGQGGWLRPALGLRLLLATAFQAVSALGAEFASEACRELGFSSNLLCSSCDLLGQFNL 
Rattus_norvegicus        1 MAAGQGGWLRPALGLRLLLATAFQAVSALGAEFSSEACRELGFSSNLLCSSCDLLGQFNL 
Heterocephalus_glaber    1 MAAGSGAWFGPAFGLRLLLASVLHAVSAFKAEFSSEACTELGFSSNLLCSSCDLLGQFNL 
 
                                                           * 
Homo_sapiens            61 LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
Sus_scrofa              61 LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
Canis_familiaris        61 LQLDPDCRRCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
Mus_musculus            61 LPLDPVCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
Rattus_norvegicus       61 LPLDPVCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
Heterocephalus_glaber   61 LQLDPDCRGCCQEEAQFETKKLYAGAILEVCGUKLGRFPQVQAFVRSDKPKLFRGLQIKY 
 
Homo_sapiens           121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI 
Sus_scrofa             121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLQRV 
Canis_familiaris       121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI 
Mus_musculus           121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI 
Rattus_norvegicus      121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI 
Heterocephalus_glaber  121 VRGSDPVLKLLDDNGNIAEELSILKWNTDSVEEFLSEKLERI 
 
 
 
Figure S8. Protein sequence alignment of the 15 kDa selenoprotein. The following sequences were used 
for alignment construction (Genbank accession numbers): Homo sapiens (NP_004252.2); Sus scrofa 
(NP_001078912.1); Rattus norvegicus (NP_579831.2); Mus musculus (Q9ERR7.3); and Canis familiaris 
(NP_001108232.1). The selenocysteine residue is highlighted in red and indicated by an asterisk. 
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Homo sapiens             1 MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSRSKYAHSSPWPAFTETIHADSVAKRPE 
Sus scrofa               1 MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSHSKYAHSSPWPAFTETIHADSVAKRPE 
Canis familiaris         1 MSFCSFFGGEVFQNHFEPGVYVCAKCGHELFSSRSKYAHSSPWPAFTETIHADSVAKRPE 
Mus musculus             1 MSFCSFFGGEVFQNHFEPGVYVCAKCSYELFSSHSKYAHSSPWPAFTETIHADSVTKCPE 
Rattus norvegicus        1 MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSRSKYAHSSPWPAFTETIHEDSVAKCPE 
Heterocephalus glaber    1 MSFCSFFGGEVFQNHFEPGIYVCAKCGYELFSSRSKYAHSSPWPAFTDAIHTDSVAKCQE 
 
                                                             * 
Homo sapiens            61 HNRSEALKVSCGKCGNGLGHEFLNDGPKPGQSRFUIFSSSLKFVPKGKETSASQGH 
Sus scrofa              61 HNRPGALKVSCGRCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFIPKGQESSPSQGQ 
Canis familiaris        61 RNSPEALKVSCGKCGNGLGHEFLNDGPKPGKSRFUIFSSSLKFIPKGKGTSGSQEA 
Mus musculus            61 KNRPEALKVSCGKCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFVPKGKEAAASQGH 
Rattus norvegicus       61 KNRPEALKVSCGKCGNGLGHEFLNDGPKRGQSRFUIFSSSLKFIPKGKEAPASQGD 
Heterocephalus glaber   61 RNRPGALKVSCGRCGNGLGHEFLNDGPKQGQSRFUIFSSSLKFIPKDKETSASQGH 
 
 
 
Figure S9. Protein sequence alignment of MsrB1. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_057416.1); Sus scrofa (NP_001090929.1); 
Canis familiaris (NP_001108221.1); Mus musculus (AAI41147.1); and Rattus norvegicus 
(NP_001037750.2). The selenocysteine residue is highlighted in red and indicated by an asterisk. 
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* 
Homo sapiens             1 MRLLLLLLVAASAMVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
Sus scrofa               1 MRLLLLFLVAASAVVRSDASANMGGVPGKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
Canis familiaris         1 MRYLLVLLVAASAVIRSDASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
Mus musculus             1 MRLLLLLLVAASAVVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
Rattus norvegicus        1 MRLLLLLLVAASAVVRSEASANLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
Heterocephalus glaber    1 --------MAASAVVRSEASGNLGGVPSKRLKMQYATGPLLKFQICVSUGYRRVFEEYMR 
 
 
Homo sapiens            61 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
Sus scrofa              61 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
Canis familiaris        61 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
Mus musculus            61 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
Rattus norvegicus       61 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
Heterocephalus glaber   53 VISQRYPDIRIEGENYLPQPIYRHIASFLSVFKLVLIGLIIVGKDPFAFFGMQAPSIWQW 
 
 
Homo sapiens           121 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
Sus scrofa             121 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
Canis familiaris       121 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
Mus musculus           121 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
Rattus norvegicus      121 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
Heterocephalus glaber  113 GQENKVYACMMVFFLSNMIENQCMSTGAFEITLNDVPVWSKLESGHLPSMQQLVQILDNE 
 
 
Homo sapiens           181 MKLNVHMDSIPHHRS 
Sus scrofa             181 MKLNVHMDSIPHHRS 
Canis familiaris       181 MKLNVHMDSIPHHRS 
Mus musculus           181 MKLNVHMDSIPHHRS 
Rattus norvegicus      181 MKLNVHMDSIPHHRS 
Heterocephalus glaber  173 MKLNVHMDSIPHHRS 
 
 
 
Figure S10. Protein sequence alignment of SelT. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_057359.2); Sus scrofa (NP_001156880.1); 
Canis familiaris (NP_001157959.1); Mus musculus (NP_001035486.2); and Rattus norvegicus 
(NP_001014275.2). The selenocysteine residue is highlighted in red and indicated by an asterisk. 
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Homo sapiens             1 MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKRRSYGNSSDSRY 
Sus scrofa               1 MVYISNGQALDSRSQSPWRLSFITDFFWGIAEFVVLFFRTLLQQDVKKRRGYGGSSDSRY 
Canis familiaris         1 MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKRRGYGNSSDSRY 
Mus musculus             1 MVYISNGQVLDSRNQSPWRVSFLTDFFWGIAEFVVFFFKTLLQQDVKKRRGYGSSSDSRY 
Rattus norvegicus        1 MVYISNGQVLDSRNQSPWRLSFITDFFWGIAEFVVFFFKTLLQQDVKKRRGYGGSSDSRY 
Chinchilla lanigera      1 MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKGRGYRNSSDSRY 
Heterocephalus glaber    1 MVYISNGQVLDSRSQSPWRLSLITDFFWGIAEFVVLFFKTLLQQDVKKGRGYRNSSDSRY 
 
                                                          * 
Homo sapiens            61 DDGRGPPGNPPRRMGRINHLRGPSPPPMAGGUGR 
Sus scrofa              61 DDGRGPPGNPPRRMGRINHLRGPNPPPMAGGUGR 
Canis familiaris        61 DDGRGPPGNPPRRMGRINHLRGPSPPPMAGGUGR 
Mus musculus            61 DDGRGPPGNPPRRMGRISHLRGPSPPPMAGGUGR 
Rattus norvegicus       61 DDGRGPPGNPPRRMGRISHLRGPSPPPMAGGUGR 
Chinchilla lanigera     61 DDGRGPPGNPPRRMGRISHLHGPSPPPMAGGUGR 
Heterocephalus glaber   61 DDGRGPPGNPPRRMGRINHLQGPSPPPMGGGUGR 
 
 
 
Figure S11. Protein sequence alignment of SelK. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_067060.2); Sus scrofa (NP_001038018.2); 
Canis familiaris (NP_001108350.1); Mus musculus (NP_064363.2); Rattus norvegicus (NP_997472.2); and 
Chinchilla lanigera (AAR26540.1). The selenocysteine residue is highlighted in red and indicated by an 
asterisk. 
 
  
11 
 
Homo sapiens             1 MERQEESLSARPALETEGLRFLHTTVGSLLATYGWYIVFSCILLYVVFQKLSARLRALRQ 
Sus scrofa               1 MEQDGDQLSARPALETEGLRFLHVTVGSLLATYGWYIVFCCILLYVVFQKLSTRLRALRQ 
Canis familiaris         1 MERDGQQLSARPALETEGLRYLHVTVGSLLATYGWYIVFSCILLYVVFQKLSTRLRALRQ 
Mus musculus             1 MDRDEEPLSARPALETESLRFLHVTVGSLLASYGWYILFSCILLYIVIQRLSLRLRALRQ 
Rattus norvegicus        1 MDRGEEPLSARPALETESLRFLHVTVGSLLASYGWYILFSCVLLYIVIQKLSLRLRALRQ 
Heterocephalus glaber    1 -----ELLSARPALETEGLRFLHVTVGSLLATYGWYILFSCILLY--------------- 
 
Homo sapiens            61 RQLDRAAAAVEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLKQLEEEKRRQKIEMWD 
Sus scrofa              61 RHLDGAAAALEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLRQLEEEKRRQKIERWD 
Canis familiaris        61 RQLDRAEAAVEPDVVVKRQEALAAARLKMQEELNAQVEKHKEKLRQLEEQKRRQKIEMWD 
Mus musculus            61 RQLDQAETVLEPDVVVKRQEALAAARLRMQEDLNAQVEKHKEKLRQLEEEKRRQKIEMWD 
Rattus norvegicus       61 RQLDQAEAVLEPDVVVKRQEALAAARLRMQEDLNAQVEKHKEKLRQLEEEKRRQKIEMWD 
Heterocephalus glaber   41 ---------------------------------NAQVEKHKEKLRQLEEEKRRQKIEMWD 
 
Homo sapiens           121 SMQEGKSYKGNAKKPQEEDSPGPSTSSVL-KRKSDRKPLRGGGYNPLSGEGGGACSWRPG 
Sus scrofa             121 SVQEGRSYRGDARKRQEEDSPGPSTSSVIPKRKSDKKPLRGGGYNPLSGEGGGACSWRPG 
Canis familiaris       121 SMQEGKSYKGNARKHPEEDSPGPSTSSVLPKRKPDRKPLRGGGYNPLSGEGGGACSWRPG 
Mus musculus           121 SMQEGRSYKRNSGRPQEEDGPGPSTSSVIPKGKSDKKPLRGGGYNPLTGEGGGTCSWRPG 
Rattus norvegicus      121 SMQEGRSYKRNSGRPQEEDGPGPSTSSVIPKGKSDKKPLRGGGYNPLTGEGGGTCSWRPG 
Heterocephalus glaber   68 SMQEGKSYKRNARKPQE-DSPGPSTSSTIPKRKSDKKPLRGSGYNPLTGEGGGACSWRPG 
 
                                   * 
Homo sapiens           180 RRGPSSGGUG 
Sus scrofa             181 RRGPSSGGUG 
Canis familiaris       181 RRGPSSGGUG 
Mus musculus           181 RRGPSSGGUN 
Rattus norvegicus      181 RRGPSSGGUS 
Heterocephalus glaber  127 RRGPSSGGUG 
 
 
 
Figure S12. Protein sequence alignment of SelS. The following sequences were used for alignment 
construction (Genbank accession numbers): Canis familiaris (NP_001108229.1); Homo sapiens 
(NP_060915.2); Mus musculus (NP_077759.3); Rattus norvegicus (NP_775143.2); and Sus scrofa 
(NP_001157585.1). The MR sequence is incomplete. The selenocysteine residue is highlighted in red and 
indicated by an asterisk. 
 
 
  
12 
 
Homo_sapiens             1 MGLPQPGLWLKRLWVLLEVAVHVVVGKVLLILFPDRVKRNILAMGEKTGMTRNPHFSHDN 
Sus_scrofa               1 MELPLPGLWLKRLWVLFQVALHVAMGKVLMTLFPGRVKQDILAMSQKTGMAKNPHFSHEN 
Canis_familiaris         1 MGLPRPVLWLRRLWVLLQVAVQVAVGKVFLKLFPARVKQHIVAMNGK-----NPHFSYDN 
Oryctolagus_cuniculus    1 MGLPRPGLWLKRLWVLVQVAVEVAVGKVLMTLFPERVKQNILAMGQKTGIAQNPNFAQDS 
Mus_musculus             1 MGLPQLWLWLKRLVIFLQVALEVAVGKVLMTLFPGRVKQSILAMGQKTGMARNPRFAPDN 
Rattus_norvegicus        1 MGLSQLWLWLKRLVIFLQVALEVATGKVLMTLFPERVKQNILAMGQKTGMTRNPRFAPDN 
Heterocephalus_glaber    1 MGLPRPGLWLKRLWVLVQVTVEVAMGKVLMTLFPDRIKKNILAMGQKTGMTRNPQFSHDN 
 
Homo_sapiens            61 WIPTFFSTQYFWFVLKVRWQRLEDTTELGGLAPNCPVVRLSGQRCNIWEFMQGNRPLVLN 
Sus_scrofa              61 WIPTFFSAQYFWFVLKVRWQRLEDKTEEGGLAPNCPVVSLSGQRCHIWDFMQGNRPLVLN 
Canis_familiaris        56 WAPTLYSMQYFWFVLKVQWQRLEDRTEPGGLAPNCPVVRLSGQRCNIWDFMQGNRPLVLN 
Oryctolagus_cuniculus   61 WIPTFFSTQYFWFVLKVRWQRLEDATEPGGLAPNCSVVRLSGQQCSVWDFMRGNRPLVLN 
Mus_musculus            61 WVPTFFSIQYFWFVLKVRWQRLEDRAEFGGLAPNCTVVCLSGQKCNIWDFIQGSRPLVLN 
Rattus_norvegicus       61 WVPTFFSIQYFWFVLKVRWQRLEDRAEYGGLAPNCTVVRLSGQKCNVWDFIQGSRPLVLN 
Heterocephalus_glaber   61 WIPTFFSTQYFWFILKVRWQRLEDTAELGGLAPDCSVVCLSGQKCTIWDFMQGNRPLVLN 
 
                                * 
Homo_sapiens           121 FGSCTUPSFMFKFDQFKRLIEDFSSIADFLVIYIEEAHASDGWAFKNNMDIRNHQNLQDR 
Sus_scrofa             121 FGSCTUPSFIFKFDQFKRLIEDFSSIADFLIIYIEEAHASDGWAFKNNVDIKNHQNLQDR 
Canis_familiaris       116 FGSCTUPSFLFKFDQFKRLIEDFCSTADFLIIYIEEAHASDGWAFKNNVNIRTHQTLQDR 
Oryctolagus_cuniculus  121 FGSCTUPSFLSKFDQFKRLIQDFSSIADFLIIYIEEAHASDGWAFKNNVDIKNHRNLQDR 
Mus_musculus           121 FGSCTUPSFLLKFDQFKRLVDDFASTADFLIIYIEEAHATDGWAFKNNVDIRQHRSLQER 
Rattus_norvegicus      121 FGSCTUPSFLLKFDQFKRLVDDFASTADFLIIYIEEAHATDGWAFKNNVDIRQHRSLQDR 
Heterocephalus_glaber  121 FGSCTUPSFMFKFDQFKRLIEDFHLIADFLIIYIEEAHASDGWAFKNNMDIRQHRNLQDR 
 
Homo_sapiens           181 LQAAHLLLARSPQCPVVVDTMQNQSSQLYAALPERLYIIQEGRILYKGKSGPWNYNPEEV 
Sus_scrofa             181 LRAAHLLLDRSPQCPVVVDTMKNQSSRLYAALPERLYVLQAGRILYKGKPGPWNYHPEEV 
Canis_familiaris       176 LQAARLLLDRAPPCPVVVDTMRNQSSQFYAALPERLFVLQEGRILYKGKPGPWNYHPEEV 
Oryctolagus_cuniculus  181 LRAASLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVLRQGRILYKGESGPWNYNPEEV 
Mus_musculus           181 VRAARLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVIQEGRICYKGKAGPWNYNPEEV 
Rattus_norvegicus      181 LRAAHLLLARSPQCPVVVDTMQNQSSQLYAALPERLYVIQEGRICYKGKPGPWNYNPEEV 
Heterocephalus_glaber  181 MRAAHLLLTKTPQCPVVVDTMQNQSSQLYAALPERLYVLQEGRILYKGKSGPWNYNPEEV 
 
Homo_sapiens           241 RAVLEKLHS-------- 
Sus_scrofa             241 RAVLEKLHS-------- 
Canis_familiaris       236 RAVLEKLHS-------- 
Oryctolagus_cuniculus  241 RAVLEELHS-------- 
Mus_musculus           241 RAVLEKLCTPPRHVPQL 
Rattus_norvegicus      241 RAVLEKLCIPPGHMPQF 
Heterocephalus_glaber  241 HAVLEKLRSQPGQIPLL 
 
 
 
Figure S13. Protein sequence alignment of DI1. The following sequences were used for alignment 
construction (Genbank accession numbers): Oryctolagus cuniculus (NP_001093428.1); Homo sapiens 
(NP_000783.2); Sus scrofa (NP_001001627.1); Mus musculus (Q61153.3); Rattus norvegicus 
(NP_067685.5); and Canis familiaris (NP_001007127.1). The selenocysteine residue is highlighted in red 
and indicated by an asterisk. 
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                                                                          * 
Homo sapiens             1 MSLLLPPLALLLLLAALVAPATAATAYRPDWNRLSGLTRARVETCGGUQLNRLKEVKAFV 
Sus scrofa               1 MHLPPLSLPLLLLLAALAA---ATTTFRPDWNRLQGLARARVETCGGUQLNRLKEVKAFV 
Canis familiaris         1 MRLPLPPPPLLLLLAALAA---AVTTFRPDWNRLHGLARARVETCGGUQLNRLKEVKAFV 
Mus musculus             1 MSILLSPPSLLLLLAALVAPATSTTNYRPDWNRLRGLARGRVETCGGUQLNRLKEVKAFV 
Rattus norvegicus        1 MNILLSPPPLLLLLAALVAPATSITTYRPDWNRLRGLARGRVETCGGUQLNRLKEVKAFV 
Heterocephalus glaber    1 -------------------------------------------TCGGUQLNRLKEVKAFV 
 
Homo sapiens            61 TQDIPFYHNLVMKHLPGADPELVLLGRRYEELERIPLSEMTREEINALVQELGFYRKAAP 
Sus scrofa              58 TQDIPLYHNLVMKHLPGADPELVLLGHRFEELERIPLSDMTREEINALVQELGFYRKAAP 
Canis familiaris        58 TQDIPLYHNLVMKHLPGADPELVLLGHHYEELERIPLSEMTREEINELVQELGFYRKAAP 
Mus musculus            61 TEDIQLYHNLVMKHLPGADPELVLLSRNYQELERIPLSQMTRDEINALVQELGFYRKSAP 
Rattus norvegicus       61 TQDIQLYHNLVMKHLPGADPELVLLSRNYQELERIPLSQMTRDEINALVQELGFYRKSAP 
Heterocephalus glaber   18 TEDIPLYHNLVMKHLPGADPELVLLNNLYEELERIPLSPMTREEINALVQELGFYRKVAR 
 
Homo sapiens           121 DAQVPPEYVWAPAKPPEETSDHADL 
Sus scrofa             118 EDPVPPEYMRAPARPAEGAPDRADL 
Canis familiaris       118 DEAVPPEYLRAPARPAEGAPDRADL 
Mus musculus           121 EAQVPPEYLWAPAKPPEEASEHDDL 
Rattus norvegicus      121 EAKVPPEYLWAPAKPPEDASDRADL 
Heterocephalus glaber   78 DAQVPPEYLWAPAKAP--------- 
 
 
 
Figure S14. Protein sequence alignment of SelM. The following sequences were used for alignment 
construction (Genbank accession numbers): Homo sapiens (NP_536355.1); Mus musculus (NP_444497.1); 
Rattus norvegicus (NP_001108485.1); Canis familiaris (NP_001108486.1); and Sus scrofa 
(NP_001155120.1). The MR sequence is incomplete. The selenocysteine residue is highlighted in red and 
indicated by an asterisk. 
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Homo sapiens             1 MAEASATGACGEAMAAAEG---SSGPAGLTLGRSFSNYRPFEPQALGLSPSWRLTGFSGM 
Sus scrofa               1 MAEAAATGAGGEMMAAVAAGEGCSGPAGLSLGRGFSGYRPFEPQALGLSPSWRLTGFSGM 
Canis familiaris         1 MAEAAATGAGGEVAAAAEG----SGSAGLSLGRGFSSYRPFEPQALGLSPSWRLTGFSGM 
Mus musculus             1 MAEAAAAGASGETMAALVAAEGSLGPAGWSAGRSFSNYRPFEPQTLGFSPSWRLTSFSGM 
Rattus norvegicus        1 MAEAAAG-ASGEAMAALVAAEGSLGPAGWSAGRSFSNYRPFEPQTLGFSPSWRLTSFSGM 
Heterocephalus glaber    1 ---------------------------------------PFEPQALGLSPSWRLTGFSGM 
 
                             * 
Homo sapiens            58 KGUGCKVPQEALLKLLAGLTRPDVRPPLGRGLVGGQEEASQEAGLPAGAGPSPTFPALGI 
Sus scrofa              61 KGUGCKVPQETLLKLLAGLTRPEVRPPVGRGLVGGLEEAAQEAGLPVRAEPSPTFPTLGI 
Canis familiaris        57 KGUGCKVPQETLLKLLAGLTRPEVRPPLGLGLVGSHEEAAQEGGLPAGADPNPTFPALGI 
Mus musculus            61 KGUGCKVPQETLLKLLEGLTRPALQPPLTSGLVGGQEETVQEGGLSTRPGPGSAFPSLSI 
Rattus norvegicus       60 KGUGCKVPQETLLKLLEGLTRPALQPPLTSGLVGGQEETVQEGGLTTRPGPGSAFPSLSI 
Heterocephalus glaber   22 KGUGCKVPQEALLKLLAGLTRP-------------------------------------- 
 
Homo sapiens           118 GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL 
Sus scrofa             121 GLDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL 
Canis familiaris       117 GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL 
Mus musculus           121 GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL 
Rattus norvegicus      120 GMDSCVIPLRHGGLSLVQTTDFFYPLVEDPYMMGRIACANVLSDLYAMGITECDNMLMLL 
Heterocephalus glaber   44 -------------------------------MMGRIACANVLSDLYAMGITECDNMLMLL 
 
Homo sapiens           178 SVSQSMSEEEREKVTPLMVKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQPNEFI 
Sus scrofa             181 SVSQNMIEEEREKITPLMIKGFRDAAEEGGTAVTGGQTVINPWIIIGGVATVVCQPNEFI 
Canis familiaris       177 SVSQSMTEEEREKITPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIVGGVATVVCQPNEFI 
Mus musculus           181 SVSQSMSEKEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQQNEFI 
Rattus norvegicus      180 SVSQSMSEKEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQQNEFI 
Heterocephalus glaber   73 SVSQNMNEEEREKVTPLMIKGFRDAAEEGGTAVTGGQTVVNPWIIIGGVATVVCQPNEFI 
 
Homo sapiens           238 MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKVKMVVSREEVELAYQEAMFNMAT 
Sus scrofa             241 MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKIKMVVSREEVELAYQEAMFNMAT 
Canis familiaris       237 MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWNKINMVVSREEVELAYQEAMFNMAT 
Mus musculus           241 MPDSAVVGDVLVLTKPLGTQVAANAHQWLDNPEKWNKIKMVVSREEVELAYQEAMFNMAT 
Rattus norvegicus      240 MPDSAVVGDVLVLTKPLGTQVAANAHQWLDNPEKWNKIKMVVSREEVELAYQEAMFNMAT 
Heterocephalus glaber  133 MPDSAVVGDVLVLTKPLGTQVAVNAHQWLDNPERWDKINMVVSREEVELAYQEAMFNMAT 
 
Homo sapiens           298 LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAVSKAS 
Sus scrofa             301 LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS 
Canis familiaris       297 LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS 
Mus musculus           301 LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQKNEVSFVIHNLPIIAKMAAISKAS 
Rattus norvegicus      300 LNRTAASLMHTFNAHAATDITGFGILGHSQNLAKQQKNEVSFVIHNLPIIAKMAAISKAS 
Heterocephalus glaber  193 LNRTAAGLMHTFNAHAATDITGFGILGHSQNLAKQQRNEVSFVIHNLPIIAKMAAISKAS 
 
Homo sapiens           358 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
Sus scrofa             361 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
Canis familiaris       357 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
Mus musculus           361 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
Rattus norvegicus      360 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
Heterocephalus glaber  253 GRFGLLQGTSAETSGGLLICLPREQAARFCSEIKSSKYGEGHQAWIVGIVEKGNRTARII 
 
Homo sapiens           418 DKPRVIEVLPRGATA--AVLAPDSSNASSEPSS 
Sus scrofa             421 DKPRVIEVLPRGTAA--TALAPENSSASSEPSL 
Canis familiaris       417 DKPRVIEVLPRGATA--TALAPDNSNASSEPSS 
Mus musculus           421 DKPRVIEVLPRGASAA-AAAAPDNSNAASEPSS 
Rattus norvegicus      420 DKPRVIEVLPRGASAS-AAAAPDNSNAASEPSS 
Heterocephalus glaber  313 DKPRVIEVLPRGAAAPALALAADNSSASSERTL 
 
Figure S15. Protein sequence alignment of SPS2. The following sequences were used for alignment 
construction (Genbank accession numbers): Canis familiaris (NP_001108208.1); Homo sapiens 
(NP_036380.2); Sus scrofa (NP_001087204.1); Rattus norvegicus (NP_001073358.2); and Mus musculus 
15 
 
(NP_033292.2). The naked mole rat sequence is incomplete. The selenocysteine residue is highlighted in 
red and indicated by an asterisk. 
Sus_scrofa               1 -----MAALRGPAGLFRWRLRVVPGGARG-------AAGQQCYDLLVIGGGSGGLACAKE 
Oryctolagus_cuniculus    1 --------MR--------------------------VAGQPTYDLLVIGGGSGGLACAKE 
Canis_familiaris         1 ---MSSCGIRAPALTWPFLSPLS-------------AAGQQNYDLLVIGGGSGGLACAKE 
Mus_musculus             1 MVAAMVAALRGPSRRFRPRTRALTRGTR---GAASAAGGQQSFDLLVIGGGSGGLACAKE 
Rattus_norvegicus        1 -MAAIVAALRGSSGRFRPQTRVLTRGTRGAAGAASAAGGQQNFDLLVIGGGSGGLACAKE 
Heterocephalus_glaber    1 ------------------------------------------------------------ 
Homo_sapiens             1 -MAAMAVALRGLGGRFRWRTQAVAGGVRG--AARGAAAGQRDYDLLVVGGGSGGLACAKE 
 
Sus_scrofa              49 AAQLGKKVAVVDYVSPSPRGTRWGLGGTCVNVGCIPKKLMHQAALLGGVIRDAPHYGWEV 
Oryctolagus_cuniculus   27 AAQLGRKVAVLDYVEPSPRGTRWGLGGTCVNVGCIPKKLMHQAALLGGAIRDAGRYGWEV 
Canis_familiaris        45 AAQLGKKVAVVDYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGSMIRDAPHYGWDV 
Mus_musculus            58 AAQLGKKVAVADYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGGMIRDAHHYGWEV 
Rattus_norvegicus       60 AAQLGRKVAVADYVEPSPRGTKWGLGGTCVNVGCIPKKLMHQAALLGGMIRDAQHYGWEV 
Heterocephalus_glaber    1 ------------------------------------------------------------ 
Homo_sapiens            58 AAQLGRKVAVVDYVEPSPQGTRWGLGGTCVNVGCIPKKLMHQAALLGGLIQDAPNYGWEV 
 
Sus_scrofa             109 VQPALHSWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNFKASFVNKHTVCGVSKGGKEI 
Oryctolagus_cuniculus   87 AQPARHDWSKMAEAIQNHVRSLNWGHRVQLQERKVKYLNVKARFIDKHTVLGVSKDKKET 
Canis_familiaris       105 AQPVLHDWRTMAEAVQNHVKSLNWGHRVQLQDRKVTYFNVKASFVNEHTVCGVAKGGKET 
Mus_musculus           118 AQPVQHNWKTMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVRGVDKGGKAT 
Rattus_norvegicus      120 AQPVQHNWKAMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVNEHTVHGVDKAGKVT 
Heterocephalus_glaber    1 ---------KMAEAVQNHVKSLNWGHRVQ----------IKASFVNKYTVCGITKGGKEM 
Homo_sapiens           118 AQPVPHDWRKMAEAVQNHVKSLNWGHRVQLQDRKVKYFNIKASFVDEHTVCGVAKGGKEI 
 
Sus_scrofa             169 LLSAEHIVIATGGRPRYPAHIEGAVEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
Oryctolagus_cuniculus  147 LLSADHIVIATGGRPRYPTLIQGASEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
Canis_familiaris       165 LLSAEHIVIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
Mus_musculus           178 LLSAEHIVIATGGRPRYPTQVKGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
Rattus_norvegicus      180 QLSAKHIVIATGGRPKYPTQVKGALEHGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
Heterocephalus_glaber   42 LLSAEHIVIATGGRPKYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYIALECAGFL 
Homo_sapiens           178 LLSADHIIIATGGRPRYPTHIEGALEYGITSDDIFWLKESPGKTLVVGASYVALECAGFL 
 
Sus_scrofa             229 TGLGLDATIMIRSIPLRAFDQQMASLVIEHMAVHGTRILKGCMPLRVEKLPDGQLQVTWV 
Oryctolagus_cuniculus  207 TGLGLDTTIMIRSIPLRGFDQQMASLVTDHMASHGTRILRGCTPSRVARLPDGRLQVTWE 
Canis_familiaris       225 TGLGLDTTIMIRSIPLRGFDQQMSSLVTEYMASQGTRFLRGCTPSRVRRLPDGQLQVTWE 
Mus_musculus           238 TGIGLDTTVMMRSIPLRGFDQQMSSLVTEHMESHGTQFLKGCVPSHIKKLPTNQLQVTWE 
Rattus_norvegicus      240 TGIGLDTTVMMRSVPLRGFDQQMASLVTEHMESHGTRFLKGCVPSLIRKLPTNQLQVTWE 
Heterocephalus_glaber  102 TGIGLDTTVMMRSIPLRGFDQQMSSLVTEHMESHGTRFLRGCTPSHIRKLPDGQLQVTWK 
Homo_sapiens           238 TGIGLDTTIMMRSIPLRGFDQQMSSMVIEHMASHGTRFLRGCAPSRVRRLPDGQLQVTWE 
 
Sus_scrofa             289 DLASDRKDVGTFDTVLWATGRVPEIGSLNLEKAGVHTNPHTQKILVDAQDATSVPHIYAI 
Oryctolagus_cuniculus  267 DRTCGKEDSGVFNTVLWAIGRVPETRGLNLEGAGVETNPESQKILVDARDTTSVPHIYAI 
Canis_familiaris       285 NLTSGKEDVGTFDTVLWAIGRIPETKSLNLEKAGVNTNPNSQKILVNAQEATSIPHIYAI 
Mus_musculus           298 DHASGKEDTGTFDTVLWAIGRVPETRTLNLEKAGISTNPKNQKIIVDAQEATSVPHIYAI 
Rattus_norvegicus      300 DLASGKEDVGTFDTVLWAIGRVPETRNLNLEKAGVNTNPKNQKIIVDAQEATSVPHIYAI 
Heterocephalus_glaber  162 DGISGKEDTGTFDTVLWAIGRVPETRSLNLEKAGVNTNSQNQKIFVDSQEATSVPHIYAI 
Homo_sapiens           298 DSTTGKEDTGTFDTVLWAIGRVPDTRSLNLEKAGVDTSPDTQKILVDSREATSVPHIYAI 
 
Sus_scrofa             349 GDVAEGRPELTPTAVMAGRLLAQRLCGRSSDLMDYDNVPTTVFTPLEYGCVGLSEEAAVA 
Oryctolagus_cuniculus  327 GDVAEGRPELTPTAIMAGKLLAQRLFGGSSDLMDYSNVPTTVFTPLEYGCVGLSEEEAVA 
Canis_familiaris       345 GDVAEGRPELTPTAIMAGRLLAQRLCGQASDVMDYDNVPTTVFTPLEYGCVGLSEEEAVT 
Mus_musculus           358 GDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLMDYSNVPTTVFTPLEYGCVGLSEEEAVA 
Rattus_norvegicus      360 GDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLMNYSNVPTTVFTPLEYGCVGLSEEEAVA 
Heterocephalus_glaber  222 GDVAEGRPELTPTAIMAG------------------------------ACVGLSEEEAVA 
Homo_sapiens           358 GDVVEGRPELTPTAIMAGRLLVQRLFGGSSDLMDYDNVPTTVFTPLEYGCVGLSEEEAVA 
 
Sus_scrofa             409 RHGEEGVEVYHAYYKPLEFTVPERDASQCYIKMVCLREPPQLVRGLHFLGPNAGEVTQGF 
Oryctolagus_cuniculus  387 RHGQEQIEVYHAYYKPLEFTVAEQDASQCYIKMVCLRQPPQPVLGLHFLGPNAGEVTQGF 
Canis_familiaris       405 RHGEEHVEVYHAYYKPLEFTVAERDASQCYVKMVCLRKPPQLVLGLHFLGPNAGEVTQGF 
Mus_musculus           418 LHGQEHVEVYHAYYKPLEFTVADRDASQCYIKMVCMREPPQLVLGLHFLGPNAGEVTQGF 
Rattus_norvegicus      420 LHGQEHIEVYHAYYKPLEFTVADRDASQCYIKMVCMREPPQLVLGLHFLGPNAGEVTQGF 
Heterocephalus_glaber  252 RHGQEHVEVYHAYYKPLEFTVAERDASQCYIKMVCLREPPQLVLGLHFLGPNAGEVTQGF 
Homo_sapiens           418 RHGQEHVEVYHAHYKPLEFTVAGRDASQCYVKMVCLREPPQLVLGLHFLGPNAGEVTQGF 
 
                                                                        * 
Sus_scrofa             469 ALALKCGASYEQVMRTVGIHPTCAEEVAKLRISKRSGLDPTVTGCUG 
Oryctolagus_cuniculus  447 ALGIKCGASYEQVIRTVGIHPTCAEEMVKLRISKRSGLDPTVTGCUG 
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Canis_familiaris       465 ALGIKCGASYAQVMRTVGIHPTCAEEVAKLRITKRSGLDPTVTGCUG 
Mus_musculus           478 ALGIKCGASYAQVMQTVGIHPTCSEEVVKLHISKRSGLEPTVTGCUG 
Rattus_norvegicus      480 ALGIQCGASYAQVMQTVGIHPTCSEEVVKLHISKRSGLDPTVTGCUG 
Heterocephalus_glaber  312 TLGIKCGASYAQVMRTVGIHPTCAEEVVKLRISKRSGLDPTVTGCUG 
Homo_sapiens           478 ALGIKCGASYAQVMRTVGIHPTCSEEVVKLRISKRSGLDPTVTGCUG 
 
 
 
Figure S16. Protein sequence alignment of mitochondrial thioredoxin reductase. The following 
sequences were used for alignment construction (Genbank accession numbers): Homo sapiens 
(BAA77601.2); Canis familiaris (XP_850181.1); Mus musculus (Q9JLT4.4); Rattus norvegicus 
(NP_072106.1); Sus scrofa (NP_001162173.1); and Oryctolagus cuniculus (XP_002722800.1). The MR 
sequence is incomplete. The selenocysteine residue is highlighted in red and indicated by an asterisk. 
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Figure S17. Expression of mouse and MR GPx1 in E. coli. Cysteine mutants of MR and mouse GPx1 
were cloned into pET28a and expressed in E. coli. (A) Proteins were isolated from identical amounts of 
bacterial culture and aliquots were analyzed by SDS-PAGE. (B) Glutathione peroxidase activity of MR and 
mouse GPx1 was measured and normalized to the amount of protein in each sample. Results are given +/- 
SD. 
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Figure S18. Expression of GPx1 in skin fibroblasts of rodents and long lived mammals. (A) Cells were labeled 
with 
75
Se followed by SDS-PAGE and autoradiography. HEK 293 cells and MEFs derived from GPx1 KO mice were 
used as positive and negative controls, respectively. Migration of the band corresponding to GPx1 is shown with an 
arrow. (B) Schematic representation of the phylogenetic tree of rodents (adapted from (46)). 
 
 
